Author

Terry A. Vik

Indiana University IndianapolisORCID 0000-0002-9883-0568Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Angela M. Matta· 2 shared Ann Marie MoormanniD· 2 shared Ann W. Kinyua· 2 shared Catherine Suzanne ForconiiD· 2 shared Christian MünziD· 2 shared Cliff I. OduoriD· 2 shared Festus N'juguna· 2 shared Jeffrey A. BaileyiD· 2 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Angela M. Matta

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Not so cold after all: tumor infiltrating CD8+ T cells in EBV-positive Burkitt lymphoma are quiescent, not exhausted

Catherine Suzanne Forconi, Cliff I. Oduor, Priya Saikumar Lakshmi, Zachary J. Racenet, Gavin Fujimori, Viriato M’Bana, Angela M. Matta, Jeni Melo, Fabienne Läderach, Titus Kipkemboi Maina, Juliana A. Otieno, Dan Chepsidor, Kibet Kibor Keitany, Festus N'juguna, Terry A. Vik, , Ann Marie Moormann

This study shows that CD8+ T cells in EBV-positive Burkitt lymphoma are not exhausted but metabolically active and may respond to immune checkpoint inhibitors.

bioRxiv · Apr 20, 2026 · PreprintImmunology

EBV Type 1 versus Type 2: A determinant of NK cell anti-tumor activity in Burkitt lymphoma

Catherine Suzanne Forconi, Lauren Shumate, Zachary J. Racenet, Viriato M’Bana, Cliff I. Oduor, Angela M. Matta, Jeni Melo, Peter O. Oluoch, Boaz Odwar, Juliana A. Otieno, Terry A. Vik, Festus N'juguna, Ann W. Kinyua, Jeffrey A. Bailey, Christian Münz, Ann Marie Moormann

This study compares ADCC activity of CD56neg and CD56dim NK cells against EBV-type 1 and 2 Burkitt lymphoma cells, finding EBV-T2 cells are more susceptible to direct cytotoxicity.

bioRxiv · Feb 10, 2026 · PreprintImmunology